| Reliant Healthcare Llc | |
|
124 N Jefferson St Hartford City IN 47348-2201 | |
| (765) 347-8279 | |
| Not Available |
| Full Name | Reliant Healthcare Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 124 N Jefferson St, Hartford City, Indiana |
| Authorized Official Name and Position | Jennifer L Clamme (MEMBER) |
| Authorized Official Contact | 7653478279 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Reliant Healthcare Llc 124 N Jefferson St Hartford City IN 47348-2201 Ph: (765) 347-8279 | Reliant Healthcare Llc 124 N Jefferson St Hartford City IN 47348-2201 Ph: (765) 347-8279 |
| NPI Number | 1861763690 |
|---|---|
| Provider Enumeration Date | 01/25/2012 |
| Last Update Date | 12/08/2015 |
| Medicare PECOS PAC ID | 8022277094 |
|---|---|
| Medicare Enrollment ID | O20120312000004 |
News Archive
Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study (KEEPS) to look at the effects of estrogen on heart disease prevention.
New research provides strong scientific evidence that long-acting reversible contraception (LARC) benefits a wider population of potential users than previously thought.
The Critical Path Institute, the Special Programme for Research and Training in Tropical Diseases, TB Alliance, and St. George's, University of London, are pleased to announce the launch of the TB-Platform for Aggregation of Clinical TB Studies.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861763690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Lindsey M Moorman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043760523 PECOS PAC ID: 4587952031 Enrollment ID: I20161017000363 |
News Archive
Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study (KEEPS) to look at the effects of estrogen on heart disease prevention.
New research provides strong scientific evidence that long-acting reversible contraception (LARC) benefits a wider population of potential users than previously thought.
The Critical Path Institute, the Special Programme for Research and Training in Tropical Diseases, TB Alliance, and St. George's, University of London, are pleased to announce the launch of the TB-Platform for Aggregation of Clinical TB Studies.
› Verified 6 days ago
News Archive
Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at Yale School of Medicine and seven other national institutions are recruiting patients to participate in the Kronos Early Estrogen Prevention Study (KEEPS) to look at the effects of estrogen on heart disease prevention.
New research provides strong scientific evidence that long-acting reversible contraception (LARC) benefits a wider population of potential users than previously thought.
The Critical Path Institute, the Special Programme for Research and Training in Tropical Diseases, TB Alliance, and St. George's, University of London, are pleased to announce the launch of the TB-Platform for Aggregation of Clinical TB Studies.
› Verified 6 days ago
Iu Health Ball Memorial Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3865 | |
Iu Health Ball Memorial Physicians Blackford Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3088 | |
Open Door Health Services, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 410 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-286-7000 Fax: 765-213-2769 | |
Preferred Family Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2005 N Walnut St, Hartford City, IN 47348 Phone: 765-348-1100 | |
Indiana University Health Jay, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 | |
Blackford Community Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 Pilgrim Blvd, Hartford City, IN 47348 Phone: 765-348-5776 Fax: 765-348-3865 |